Investing in Life Science Innovation

TVM Capital Life Science is a group of independent investment advisories and fund managers for Venture Capital funds, investing into innovative biotech, pharmaceutical, and medtech companies in Europe, Canada the USA and Asia, with teams based in Munich and Montreal.

Learn more

Home
About Us
Team
Senior Advisors
Portfolio
News
Events
Contact

Main Content

F-star Announces Early Exercise by Denali Therapeutics of its Option to Acquire F-star Gamma

June 7, 2018

Lilly to Acquire AurKa Pharma

May 14, 2018

Rapid Micro Biosystems Secures $60 Million In Equity Financing

May 8, 2018

Footer

About Us

We are creating sustainable value – for patients, the pharmaceutical industry and our investors. Since 1984, TVM Capital Life Science has invested in more than 130 life science companies in Europe, Canada and the United States, currently managing in excess of €900 million from more than 50 investors.

Our Team

TVM Capital Life Science operates with an integrated team from its offices in Montreal and Munich. Our mission is to invest in the development of exciting life science products and the growth of substantial companies in the field that are or aspire to be innovative leaders in their market segment.

Offices

TVM Capital GmbH
Munich, Germany

TVM Life Science Management GmbH
Munich, Germany

TVM Life Science Management Inc.
Montreal, Westmount, Canada

li

TVM Capital Group
TVM Capital Healthcare
TVM Capital Life Science

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok No Read more

Revoke Cookies